Literature DB >> 8640671

Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.

D Ichikawa1, N Hashimoto, M Hoshima, T Yamaguchi, K Sawai, Y Nakamura, T Takahashi, T Abe, J Inazawa.   

Abstract

BACKGROUND: Biopsy by fine-needle, aspiration has become a routine technique for the diagnosis of a dominant breast mass. In this study, fluorescent in situ, hybridization (FISH) analysis of interphase nuclei allowed the authors to detect genetic aberrations that are difficult to identify by conventional cytology.
METHODS: To investigate ways of minimizing misdiagnosis of the cytology of breast tumors, and detecting genetic aberrations preoperatively, the authors performed FISH with specimens obtained by fine-needle aspiration biopsies of 106 primary breast tumors (78 primary breast cancers, 2 phyllodes tumors, and 26 benign breast tumors). Numerical chromosome aberrations were investigated using 3-color FISH performed with (peri)centromere-specific probes for chromosomes 1, 11, and 17.
RESULTS: Sufficient materials for FISH analysis were obtained with aspiration biopsy from 98 of the 106 breast tumors (93.4%). None of the benign tumors nor phyllodes tumors showed evidence of aneusomy for any of the 3 chromosomes. However, 71 of the 74 breast cancers (95.9%) for which sufficient material was available demonstrated aneusomy of at least 1 of the 3 chromosomes tested. The FISH analysis also suggested a possible correlation between aneusomy of chromosome 17 and metastasis to regional lymph nodes (chi-square test = 7.78; P < 0.05).
CONCLUSIONS: FISH analysis of fine-needle aspiration biopsies can be a practical and useful method for the preoperative diagnosis of breast carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 8640671     DOI: 10.1002/(SICI)1097-0142(19960515)77:10<2064::AID-CNCR15>3.0.CO;2-T

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization.

Authors:  H Tsuda; T Takarabe; N Susumu; J Inazawa; S Okada; S Hirohashi
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Evaluation of stable and highly productive gene amplified CHO cell line based on the location of amplified genes.

Authors:  T Yoshikawa; F Nakanishi; S Itami; D Kameoka; T Omasa; Y Katakura; M Kishimoto; K Suga
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

3.  Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Authors:  Anna Zaczek; Aleksandra Markiewicz; Anna Supernat; Natalia Bednarz-Knoll; Burkhardt Brandt; Barbara Seroczyńska; Jarosław Skokowski; Jolanta Szade; Piotr Czapiewski; Wojciech Biernat; Marzena Wełnicka-Jaśkiewicz; Jacek Jassem
Journal:  Pathol Oncol Res       Date:  2012-03-18       Impact factor: 3.201

4.  Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer.

Authors:  V Dutta; G S Chopra; K Sahai; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis.

Authors:  J C Estrada; C Albo; A Benguría; A Dopazo; P López-Romero; L Carrera-Quintanar; E Roche; E P Clemente; J A Enríquez; A Bernad; E Samper
Journal:  Cell Death Differ       Date:  2011-12-02       Impact factor: 15.828

Review 6.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

7.  Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.

Authors:  Matteo Brunelli; Alessia Nottegar; Giuseppe Bogina; Anna Caliò; Luca Cima; Albino Eccher; Caterina Vicentini; Lisa Marcolini; Aldo Scarpa; Serena Pedron; Eleonora Brunello; Sakari Knuutila; Anna Sapino; Caterina Marchiò; Emilio Bria; Annamaria Molino; Luisa Carbognin; Giampaolo Tortora; Bharat Jasani; Keith Miller; Ibrahim Merdol; Lucia Zanatta; Licia Laurino; Tiina Wirtanen; Giuseppe Zamboni; Marcella Marconi; Marco Chilosi; Erminia Manfrin; Guido Martignoni; Franco Bonetti
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 8.  Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.

Authors:  Monica M Reinholz; Amy K Bruzek; Daniel W Visscher; Wilma L Lingle; Matthew J Schroeder; Edith A Perez; Robert B Jenkins
Journal:  Lancet Oncol       Date:  2009-03       Impact factor: 41.316

9.  Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions.

Authors:  Jingquan Han; Shouqiang Cao; Kai Zhang; Guibin Zhao; Yanzhong Xin; Qing Dong; Yubo Yan; Jian Cui
Journal:  J Cardiothorac Surg       Date:  2012-11-13       Impact factor: 1.637

10.  Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH).

Authors:  M Fiegl; A Massoner; M Haun; W Sturm; H Kaufmann; R Hack; J Krugmann; M Fritzer-Szekeres; K Grünewald; G Gastl
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.